Alexa

J&J warns of allergic reactions with HIV drug

J&J warns of allergic reactions with HIV drug

Johnson & Johnson is warning doctors about reports of potentially deadly allergic reactions in patients taking its HIV drug Intelence.
J&J's Tibotec unit has issued a letter to physicians about severe skin reactions and liver damage among patients taking the drug. The U.S. regulatory Food and Drug Administration has added information about the side effects to the drug's labeling.
The skin reactions included cases of Stevens-Johnson Syndrome, a life-threatening skin disorder that begins with fever, sore throat and fatigue.
The new label warns physicians to discontinue use of the drug if patients develop rash, fever, fatigue and other signs of an adverse reaction.
Intelence, approved in January, works by blocking the enzyme HIV needs to multiply.


Updated : 2021-03-01 10:00 GMT+08:00